Central serous chorioretinopathy: update on pathophysiology and treatment.
about
Interventions for central serous chorioretinopathy: a network meta-analysisInterventions for central serous chorioretinopathy: a network meta-analysisProfile of verteporfin and its potential for the treatment of central serous chorioretinopathyCharacteristics of intraretinal deposits in acute central serous chorioretinopathyFUNDUS AUTOFLUORESCENCE LIFETIMES AND CENTRAL SEROUS CHORIORETINOPATHY.Corticosteroid-associated atypical central serous chorioretinopathy in a patient with multiple sclerosis.Clinical features of serous retinopathy observed with cobimetinib in patients with BRAF-mutated melanoma treated in the randomized coBRIM studyClinical application of optical coherence tomography in combination with functional diagnostics: advantages and limitations for diagnosis and assessment of therapy outcome in central serous chorioretinopathyCorrelation of subretinal fluid volume with choroidal thickness and macular volume in acute central serous chorioretinopathy.Persistent unilateral central serous chorioretinopathy in a breastfeeding woman.Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab.QT interval dispersion in the patients with central serous chorioretinopathyFocal laser photocoagulation and photodynamic therapy for lupus choroidopathy.The chorioretinal damage caused by different half parameters of photodynamic therapy in rabbits.Short-term efficacy of subthreshold micropulse yellow laser (577-nm) photocoagulation for chronic central serous chorioretinopathy.Oral Rifampin treatment for longstanding chronic central serous chorioretinopathy.Central serous chorioretinopathy: what we have learnt so far.Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial.Effects of low-level laser irradiation on proliferation and functional protein expression in human RPE cells.Central serous chorioretinopathy and systemic corticosteroids in rheumatic diseases: report of three cases.Half-dose photodynamic therapy followed by diode micropulse laser therapy as treatment for chronic central serous chorioretinopathy: evaluation of a prospective treatment protocol.Structural Changes of Inner and Outer Choroid in Central Serous Chorioretinopathy Determined by Optical Coherence Tomography.Evaluation of Choroidal Thickness and Volume during the Third Trimester of Pregnancy using Enhanced Depth Imaging Optical Coherence Tomography: A Pilot Study.Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of lifeClinical efficacy of anti-VEGF medications for central serous chorioretinopathy: a meta-analysis.Atypical chronic central serous chorioretinopathy with cystoid macular edema: Therapeutic response to medical and laser therapy.Unilateral central serous chorioretinopathy in a pregnant Nigerian womanOral Mineralocorticoid-Receptor Antagonists: Real-Life Experience in Clinical Subtypes of Nonresolving Central Serous Chorioretinopathy With Chronic Epitheliopathy.Half-dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy.Finasteride is effective for the treatment of central serous chorioretinopathy.Multimodal Imaging Evaluations of Focal Choroidal Excavations in Eyes with Central Serous Chorioretinopathy.Anatomical and Gene Expression Changes in the Retinal Pigmented Epithelium Atrophy 1 (rpea1) Mouse: A Potential Model of Serous Retinal Detachment.High-Resolution Imaging of Intraretinal Structures in Active and Resolved Central Serous Chorioretinopathy.Subfoveal Choroidal Thickness in Central Serous Chorioretinopathy: A Meta-Analysis.Factors affecting the visual outcome in acute central serous chorioretinopathy.Fully Automated Robust System to Detect Retinal Edema, Central Serous Chorioretinopathy, and Age Related Macular Degeneration from Optical Coherence Tomography Images.Photodynamic therapy for central serous chorioretinopathy.Unintentional secondary exogenous corticosteroid exposure and central serous chorioretinopathyIs myopia a protective factor against central serous chorioretinopathy?Repeated subretinal surgery and removal of subretinal decalin is well tolerated - evidence from a porcine model.
P2860
Q24186996-00A7ADDC-1211-4967-B169-E455DB9ECE93Q24188115-8BF0F12F-B26F-479A-8B11-5E08EFABDF69Q26824756-E0BF1DE1-BEDD-47EC-9EEF-C90CFAFB6EE0Q26830639-D89DB47D-25E7-4C8C-BCB1-1E1D2AFD57C4Q30490714-B7B9EB4A-71C8-4B22-B707-349CD83B9DA0Q33706152-091524CF-53A4-4EB8-98E2-F59513307846Q33830941-FEB15305-4D97-44C3-B636-D10E9CA11267Q34584359-94697EC4-1EB8-41F1-8B16-070FAEF23E1FQ34718462-C11A6EA9-E89D-4AF2-B47C-85F62C23DB22Q34904291-FC00F9FC-7309-40D6-A7D7-0D2F4E69C4E5Q34958682-B3C67255-2B09-4024-AA57-EC617C6643D6Q35075372-CD67B7FB-5EF1-4226-B120-B10218524A90Q35087088-50CA6FFE-5B2C-40F5-B388-0DCD725A4075Q35192101-A9575E56-DA86-4444-B0EF-14B50DB3D200Q35567966-6FDD8424-21ED-49B4-BBDB-CF5A4D0B160AQ35582953-00E0D7D2-8472-45AB-AFDB-2E45EB344B69Q35680278-634E9C3F-97AB-48AB-89AE-C963EFCE77F5Q35782233-914CAFA3-93EC-4989-AC34-21FEFBFAA1BEQ35787334-3714EDE6-4B63-4276-8634-3A4D96B15CA9Q35861558-7235E27F-48CD-45E0-86EF-3BE0C4B06108Q35869490-39051332-B47E-4FF5-A1DE-829CD856688BQ36053142-7691D327-9E4C-4725-9DAB-4E3CE5CFEC65Q36077387-B240670F-1E4B-461A-8E42-F7F843FB9B5BQ36239882-E21ECAA7-2A5B-4BFA-99D8-D9281DACB815Q36339246-81F6163D-E5B4-4E80-96C2-CEE182E60F7AQ36408674-B1E4CA98-169E-484A-80C7-F330E34AE2B9Q36423744-CFF556E0-226C-42C9-8F8C-0670DC1FDE07Q36663776-8D4DB442-59CA-4B30-8494-6BAE91854138Q36883236-87FFC31F-1EC2-4BB7-8180-0C88E58BF940Q37000742-BAF60BDA-CFA7-4532-8875-D46936A89D75Q37089196-2EBD28F8-162E-4566-88F4-151622D7C330Q37420198-5DDF8B3B-D2E9-4497-BD6F-62AACA0A922FQ37579624-E1FE2B80-DB00-45C0-9E6E-B745E3550C8DQ37580515-21E85B5D-C3FC-4AE0-9A9E-21D6B4884871Q37723609-D981AF3D-146E-492F-8842-D8811C1C54FEQ37739328-ABD3BAAF-7F23-4C0E-98F9-94F3E47CF385Q38221648-92D085AD-E626-4F86-B842-16470EC1C648Q38319742-C3B3F59F-A333-4531-8630-01E71992E233Q38580269-66868B75-7B88-43AF-BA73-88DC37C761AEQ38671629-135CAACF-4CB5-4AA6-8164-69E7AA2D8E55
P2860
Central serous chorioretinopathy: update on pathophysiology and treatment.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Central serous chorioretinopathy: update on pathophysiology and treatment.
@ast
Central serous chorioretinopathy: update on pathophysiology and treatment.
@en
Central serous chorioretinopathy: update on pathophysiology and treatment.
@nl
type
label
Central serous chorioretinopathy: update on pathophysiology and treatment.
@ast
Central serous chorioretinopathy: update on pathophysiology and treatment.
@en
Central serous chorioretinopathy: update on pathophysiology and treatment.
@nl
prefLabel
Central serous chorioretinopathy: update on pathophysiology and treatment.
@ast
Central serous chorioretinopathy: update on pathophysiology and treatment.
@en
Central serous chorioretinopathy: update on pathophysiology and treatment.
@nl
P2093
P2860
P1476
Central serous chorioretinopathy: update on pathophysiology and treatment.
@en
P2093
Benjamin Nicholson
Catherine Meyerle
Farzin Forooghian
Jason Noble
P2860
P304
P356
10.1016/J.SURVOPHTHAL.2012.07.004
P577
2013-03-01T00:00:00Z